A Brief Narrative Review of the Underlying Mechanisms Whereby Omega-3 Fatty Acids May Influence Skeletal Muscle: From Cell Culture to Human Interventions

• Published in: Nutrients 2023-06, Vol.15 (13), p.2926
• Main Authors: Taheri, Maryam, Chilibeck, Philip D, Cornish, Stephen M
• Format: Article
• Language: English
• Subjects: Adults; Aged; anabolic; Animal models; Animals; Apoptosis; Atrophy; Cell culture; Cell Culture Techniques; Cells (biology); Fatty acids; Fatty Acids, Omega-3 - metabolism; Fatty Acids, Omega-3 - pharmacology; Homeostasis; Humans; Inflammation; Insulin; Insulin Resistance; Kinases; Locomotion; mechanism; Muscle strength; Muscle, Skeletal - metabolism; Muscles; Musculoskeletal system; Older people; omega-3; Phosphorylation; Physiology; Protein biosynthesis; Protein synthesis; Proteins; Review; Reviews; Sarcopenia; Sarcopenia - drug therapy; Sarcopenia - metabolism; Sarcopenia - prevention & control; Satellite cells; Skeletal muscle; Transcription factors; Tumor necrosis factor-TNF
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15132926

Skeletal muscle is essential for human locomotion as well as maintaining metabolic homeostasis. Age-related reduction in skeletal muscle mass, strength, and function (i.e., sarcopenia) is a result of pathophysiological processes that include inflammation, alteration of molecular signaling for muscle protein synthesis and degradation, changes in insulin sensitivity, as well as altered skeletal muscle satellite cell activity. Finding strategies to mitigate skeletal muscle loss with age is deemed paramount as the percentage of the population continues to shift towards having more older adults with sarcopenia. Recent research indicates omega-3 fatty acid supplementation can influence anabolic or catabolic pathways in skeletal muscle. Our brief review will provide a synopsis of some underlying mechanisms that may be attributed to omega-3 fatty acid supplementation's effects on skeletal muscle. We will approach this review by focusing on cell culture, animal (pre-clinical models), and human studies evaluating omega-3 fatty acid supplementation, with suggestions for future research. In older adults, omega-3 fatty acids may possess some potential to modify pathophysiological pathways associated with sarcopenia; however, it is highly likely that omega-3 fatty acids need to be combined with other anabolic interventions to effectively ameliorate sarcopenia.